β-D-glucan testing

Aspergillosis: From Diagnosis to Prevention

Volumn , Issue , 2010, Pages 125-133

  Yoshida, Minoru ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Beta glucan; Diagnosis; Fungitell; Invasive aspergillosis; Preemptive therapy

Indexed keywords

EID: 80052043050     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-2408-4_8     Document Type: Chapter

References (43)

1. Denning, D. W. (1998) Invasive aspergillosis. Clin Infect Dis, 26, 781-803, quiz 4-5.
2. Obayashi, T., Yoshida, M., Tamura, H., Aketagawa, J., Tanaka, S. & Kawai, T. (1992) Determination of plasma (1→3)-β-D-glucan: a new diagnostic aid to deep mycosis. J Med Vet Mycol, 30, 275-80.
3. Morita, T., Tanaka, S. & Nakamura, T. (1981) A new (1→3)-β-D-glucan-mediated coagulation pathway found in limulus amebocytes. FEBS Lett, 129, 318-21.
4. Obayashi, T., Tamura, H., Tanaka, S., Ohki, M., Takahashi, S., Arai, M., Masuda, M. & Kawai, T. (1985) A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta, 149, 55-65.
5. Yoshida, M., Obayashi, T., Tamura, H., Tanaka, S., Kawai, T., Sakamoto, S. & Miura, Y. (1994) Diagnostic and prognostic significance of plasma endotoxin determination in febrile patients with haematological malignancies. Eur J Cancer, 30A, 145-7.
6. Miyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N. & Hara, K. (1995) Plasma (1→3)-β-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol, 33, 3115-8.
7. Obayashi, T., Yoshida, M., Mori, T., Goto, H., Yasuoka, A., Iwasaki, H., Teshima, H., Kohno, S., Horiuchi, A., Ito, A. et al. (1995) Plasma (1→3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet, 345, 17-20.
8. Yoshida, M., Obayashi, T., Iwama, A., Ito, M., Tsunoda, S., Suzuki, T., Muroi, K., Ohta, M., Sakamoto, S. & Miura, Y. (1997) Detection of plasma (1→3)-β-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol, 35, 371-4.
9. Obayashi, T., Negishi, K., Suzuki, T. & Funata, N. (2008) Reappraisal of the serum (1→3) - β-D-glucan assay for the diagnosis of invasive fungal infections - a study based on autopsy cases from 6 years. Clin Infect Dis, 46, 1864-70.
10. Tamura, H., Arimoto, Y., Tanaka, S., Yoshida, M., Obayashi, T. & Kawai, T. (1994) Automated kinetic assay for endotoxin and (1→3)-β-D-glucan in human blood. Clin Chim Acta, 226, 109-12.
11. Mori, T., Ikemoto, H., Matsumura, M., Yoshida, M., Inada, K., Endo, S., Ito, A., Watanabe, S., Yamaguchi, H., Mitsuya, M., Kodama, M., Tani, T., Yokota, T., Kobayashi, T., Kambayashi, J., Nakamura, T., Masaoka, T., Teshima, H., Yoshinaga, T., Kohno, S., Hara, K. & Miyazaki, S. (1997) Evaluation of plasma (1→3)-β-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clin Chem Clin Biochem, 35, 553-60.
12. Horiguchi, Y. (2004) The performance of (1→ 3)-β-D-glucan and Aspergillus galactomannan measurement for early diagnosis of invasive aspergillosis in patients with hematological diseases. Kansenshogaku Zasshi, 78, 566-73.
13. Kami, M., Fukui, T., Ogawa, S., Kazuyama, Y., Machida, U., Tanaka, Y., Kanda, Y., Kashima, T., Yamazaki, Y., Hamaki, T., Mori, S., Akiyama, H., Mutou, Y., Sakamaki, H., Osumi, K., Kimura, S. & Hirai, H. (2001) Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis, 33, 1504-12.
14. Kawazu, M., Kanda, Y., Nannya, Y., Aoki, K., Kurokawa, M., Chiba, S., Motokura, T., Hirai, H. & Ogawa, S. (2004) Prospective comparison of the diagnostic potential of realtime PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1→3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol, 42, 2733-41.
15. Mori, T. & Matsumura, M. (2000) Study on the influence of pretreatment temperature for plasma (1→3)-β-D-glucan measurement using kinetic turbidimetric Limulus assay and clinical evaluation of (1→3)-β-D-glucan measurement methods. Nippon Ishinkin Gakkai Zasshi, 41, 169-76.
16. Moro, H., Tsukada, H., Ohara, T., Susa, R., Tanabe, Y., Suzuki, E. & Gejyo, F. (2003) Comparison of four diagnostic methods using clinical blood by measuring (1→3)-β-D-glucan. Kansenshogaku Zasshi, 77, 227-34.
17. Yoshida, K., Niki, Y., Ohno, M., Watanabe, S., Hashiguchi, K., Nakajima, M. & Matsushima, T. (1997) Clinical significance of (1→3)-β-D-glucan in pleural effusion and liquor. Kansenshogaku Zasshi, 71, 1210-5.
18. Yoshida, M. (2008) Deep mycosis in patients with hematological diseases. Rinsho Ketsueki, 49, 567-75.
19. Yoshida, M. & Ohno, R. (2004) Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey. Clin Infect Dis, 39(Suppl 1), S11-4.
20. Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H. & Ostrosky-Zeichner, L. (2004) β-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis, 39, 199-205.
21. Koo, S., Bryar, J., Page, J. H., Baden, L. R. & Marty, F. M. Clinical utility of the (1→3)-β-D-glucan assay in the diagnosis of invasive fungal infections. in 46th Interscience Conference on Antimicrobial Agents and Chemotheraphy. 2006.
22. Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., Finkelman, M. A. & Rex, J. H. (2005) Multicenter clinical evaluation of the (1→3)-β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis, 41, 654-9.
23. Pazos, C., Ponton, J. & Del Palacio, A. (2005) Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol, 43, 299-305.
24. Persat, F., Ranque, S., Derouin, F., Michel-Nguyen, A., Picot, S. & Sulahian, A. (2008) Contribution of the (1→3)-β-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol, 46, 1009-13.
25. Hossain, M. A., Miyazaki, T., Mitsutake, K., Kakeya, H., Yamamoto, Y., Yanagihara, K., Kawamura, S., Otsubo, T., Hirakata, Y., Tashiro, T. & Kohno, S. (1997) Comparison between Wako-WB003 and Fungitec G tests for detection of (1→3)-β-D-glucan in systemic mycosis. J Clin Lab Anal, 11, 73-7.
26. Senn, L., Robinson, J. O., Schmidt, S., Knaup, M., Asahi, N., Satomura, S., Matsuura, S., Duvoisin, B., Bille, J., Calandra, T. & Marchetti, O. (2008) 1, 3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis, 46, 878-85.
27. Moro, H., Tsukada, H., Ohara, T., Susa, R., Tanabe, Y., Suzuki, E. & Gejyo, F. (2003) Clinical evaluation of performance of a new diagnostic method for deep mycosis by measuring betaglucan concentration in the blood. Kansenshogaku Zasshi, 77, 219-26.
28. De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., Denning, D. W., Patterson, T. F., Maschmeyer, G., Bille, J., Dismukes, W. E., Herbrecht, R., Hope, W. W., Kibbler, C. C., Kullberg, B. J., Marr, K. A., Munoz, P., Odds, F. C., Perfect, J. R., Restrepo, A., Ruhnke, M., Segal, B. H., Sobel, J. D., Sorrell, T. C., Viscoli, C., Wingard, J. R., Zaoutis, T. & Bennett, J. E. (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis, 46, 1813-21.
29. Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., Van Burik, J. A., Wingard, J. R. & Patterson, T. F. (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis, 46, 327-60.
30. Kato, A., Takita, T., Furuhashi, M., Takahashi, T., Maruyama, Y. & Hishida, A. (2001) Elevation of blood (1→3)-β-D-glucan concentrations in hemodialysis patients. Nephron, 89, 15-9.
31. Nakao, A., Yasui, M., Kawagoe, T., Tamura, H., Tanaka, S. & Takagi, H. (1997) False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology, 44, 1413-8.
32. Ikemura, K., Ikegami, K., Shimazu, T., Yoshioka, T. & Sugimoto, T. (1989) False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products. J Clin Microbiol, 27, 1965-8.
33. Ogawa, M., Hori, H., Niiguchi, S., Azuma, E. & Komada, Y. (2004) False-positive plasma (1→3)-β-D-glucan test following immunoglobulin product replacement in an adult bone marrow recipient. Int J Hematol, 80, 97-8.
34. Mennink-Kersten, M. A., Warris, A. & Verweij, P. E. (2006) 1, 3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid. N Engl J Med, 354, 2834-5.
35. Ishizuka, Y., Tsukada, H. & Gejyo, F. (2004) Interference of (1→3)-β-D-glucan administration in the measurement of plasma (1→3)-β-D-glucan. Intern Med, 43, 97-101.
36. Yoshida, K., Niki, Y., Matsuda, J., Hirakata, Y., Oda, T., Aketagawa, J., Obayashi, T., Kohno, S. & Oka, M. (2005) Evaluation of an improved pretreatment method for the measurement of (1→3)-β-D-glucan in blood samples. Kansenshogaku Zasshi, 79, 433-42.
37. Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V., Shenep, J. L. & Young, L. S. (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis, 34, 730-51.
38. Yoshida, M. (2006) Usefulness of determination of β-D-glucan in the diagnosis of deep mycosis - Experience in Japan. Med Mycol, 44, S185-9.
39. Masaoka, T. (2004) Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary. Clin Infect Dis, 39(Suppl 1), S49-52.
40. Maertens, J., Theunissen, K., Verhoef, G., Verschakelen, J., Lagrou, K., Verbeken, E., Wilmer, A., Verhaegen, J., Boogaerts, M. & Van Eldere, J. (2005) Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis, 41, 1242-50.
41. Yoshida, M., Roth, R. I., Grunfeld, C., Feingold, K. R. & Levin, J. (1996) Soluble (1→3)-β-D-glucan purified from Candida albicans: biologic effects and distribution in blood and organs in rabbits. J Lab Clin Med, 128, 103-14.
42. Miceli, M. H., Grazziutti, M. L., Woods, G., Zhao, W., Kocoglu, M. H., Barlogie, B. & Anaissie, E. (2008) Strong correlation between serum Aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin Infect Dis, 46, 1412-22.
43. Yasuoka, A., Tachikawa, N., Shimada, K., Kimura, S. & Oka, S. (1996) (1→3)-β-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia. Clin Diagn Lab Immunol, 3, 197-9.